1. Home
  2. HWBK vs GNFT Comparison

HWBK vs GNFT Comparison

Compare HWBK & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWBK
  • GNFT
  • Stock Information
  • Founded
  • HWBK 1865
  • GNFT 1999
  • Country
  • HWBK United States
  • GNFT France
  • Employees
  • HWBK N/A
  • GNFT N/A
  • Industry
  • HWBK Major Banks
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HWBK Finance
  • GNFT Health Care
  • Exchange
  • HWBK Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • HWBK 205.8M
  • GNFT 214.5M
  • IPO Year
  • HWBK N/A
  • GNFT 2019
  • Fundamental
  • Price
  • HWBK $27.13
  • GNFT $3.55
  • Analyst Decision
  • HWBK
  • GNFT Strong Buy
  • Analyst Count
  • HWBK 0
  • GNFT 1
  • Target Price
  • HWBK N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • HWBK 17.0K
  • GNFT 2.9K
  • Earning Date
  • HWBK 07-29-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • HWBK 2.91%
  • GNFT N/A
  • EPS Growth
  • HWBK 816.74
  • GNFT N/A
  • EPS
  • HWBK 2.75
  • GNFT 0.03
  • Revenue
  • HWBK $72,980,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • HWBK N/A
  • GNFT $15.98
  • Revenue Next Year
  • HWBK N/A
  • GNFT N/A
  • P/E Ratio
  • HWBK $10.21
  • GNFT $125.45
  • Revenue Growth
  • HWBK 34.33
  • GNFT 105.01
  • 52 Week Low
  • HWBK $19.75
  • GNFT $2.55
  • 52 Week High
  • HWBK $35.95
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • HWBK 35.08
  • GNFT 40.25
  • Support Level
  • HWBK $28.12
  • GNFT $3.80
  • Resistance Level
  • HWBK $28.76
  • GNFT $4.61
  • Average True Range (ATR)
  • HWBK 0.87
  • GNFT 0.11
  • MACD
  • HWBK -0.14
  • GNFT -0.06
  • Stochastic Oscillator
  • HWBK 0.00
  • GNFT 5.59

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: